Health and Healthcare
Aikido Pharma Could Be the Next Big Name in the Coronavirus Fight
Published:
Aikido Pharma Inc. (NASDAQ: AIKI) is not necessarily a household name, but on Tuesday its shares made waves. The stock more than doubled on news that the company had secured a worldwide license agreement regarding a coronavirus treatment.
Specifically, the company announced that it secured an exclusive worldwide license for a broad spectrum antiviral drug platform. The licensed technology is a broadly acting pan-viral inhibitory compound with efficacy against multiple viral pathogens.
The key point here is that the technology works to inhibit replication of multiple viruses, including influenza viruses, SARS-COV (a coronavirus), MERS-COV, ebolaviruses and Marburg virus.
Some quick background: Aikido has a portfolio of small molecule anti-cancer therapeutics. The pipeline includes therapies for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia.
Anthony Hayes, CEO of Aikido commented:
This license is a follow up to our March 6, 2020 press release ‘Treatment for Coronavirus Optioned by Spherix.’ We continue to vet the technology we optioned, but this antiviral drug platform technology we’ve licensed is broader with more potential applicability, while also coming from the same lead inventors and institution. We are always seeking to acquire the best technology to drive shareholder value. We will continue to investigate the technology covered by our option and we will be providing additional information about this antiviral platform shortly. Working to develop technology to help with the current pandemic, as well as other possible viruses that may impact us in the future, is our goal for this technology.
Aikido Pharma stock traded up about 185% to $1.91 on Tuesday, in a 52-week range of $0.48 to $2.74.
24/7 Wall St.The Average American Is Losing Their Savings Every Day (Sponsor)
If you’re like many Americans and keep your money ‘safe’ in a checking or savings account, think again. The average yield on a savings account is a paltry .4% today, and inflation is much higher. Checking accounts are even worse.
Every day you don’t move to a high-yield savings account that beats inflation, you lose more and more value.
But there is good news. To win qualified customers, some accounts are paying 9-10x this national average. That’s an incredible way to keep your money safe, and get paid at the same time. Our top pick for high yield savings accounts includes other one time cash bonuses, and is FDIC insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes and your money could be working for you.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
